Lilly Acquires ICOS To Bring Full Value Of Cialis In House
This article was originally published in The Pink Sheet Daily
Executive Summary
$2.1 bil. deal will allow Lilly to benefit from efficiencies in development, marketing and sales of the erectile dysfunction product.
You may also be interested in...
People In The News: Tracking The Latest Industry Personnel Moves
Presidents And CEOs
People In The News: Tracking The Latest Industry Personnel Moves
Presidents And CEOs
Abbott Extends Antibody Target Deal With Caprion
Abbott adds two years to exclusive agreement for rights to 10 NSCLC targets identified by Canadian proteomics firm.